Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen

Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen

Abstract Background It remains controversial whether palliative primary tumor resection (PPTR) can provide survival benefits to the patients with metastatic colorectal cancer (mCRC) who have unresectable metastases. The aim of this study was to evaluate whether PPTR could improve the survival of pat...

Full description

Bibliographic Details
Main Authors: Wen-Zhuo He, Yu-Ming Rong, Chang Jiang, Fang-Xin Liao, Chen-Xi Yin, Gui-Fang Guo, Hui-Juan Qiu, Bei Zhang, Liang-Ping Xia
Format: Article
Language:English
Published: BMC 2016-06-01
Series:Chinese Journal of Cancer
Subjects:
Metastatic colorectal cancer
Palliative primary tumor resection
Overall survival
Lactate dehydrogenase
Carcinoembryonic antigen
Online Access:http://link.springer.com/article/10.1186/s40880-016-0120-4

Internet

http://link.springer.com/article/10.1186/s40880-016-0120-4

Similar Items